Charter Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$258K Buy
987
+1
+0.1% +$256 0.12% 60
2026
Q2
$248K Buy
986
+1
+0.1% +$215 0.11% 61
2026
Q1
$214K Buy
+985
New +$218K 0.11% 66

Other funds holding ABBV

Charter Capital Management's ABBV Position: Q3 2026 in Review

Charter Capital Management increased its AbbVie (ABBV) stake by 0.1% in Q3 2026, buying an estimated $256 and bringing the position to 987 shares worth $258K. The position accounts for 0.12% of the portfolio, ranked #60.

Charter Capital Management first reported a position in ABBV in Q1 2026 and has held it in 3 quarters since. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Charter Capital Management held 987 shares of AbbVie worth $258K as of Q3 2026.
  • Charter Capital Management bought 1 AbbVie share in Q3 2026, an estimated $256.
  • AbbVie made up 0.12% of Charter Capital Management's portfolio in Q3 2026, its #60 holding.
  • Charter Capital Management first reported a position in AbbVie in Q1 2026 and has held it in 3 quarters since.
  • 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Charter Capital Management's 13F filing for Q3 2026, filed 28 Oct 2026.